|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 802.13 USD | -1.77% |
|
+2.92% | +22.73% |
| 02-13 | Novotek Reports Decline in Revenue and Operating Profit | FW |
| 02-12 | Analyst recommendations: Pfizer, Applovin, Biogen, Hilton, Snap… |  |
Main competitors
| Change | 5d. change | 1 months change | 3 months change | Varia. Jan 1. | 1-year change | 3-years change | 5-years change | 10-years change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.77% | +2.92% | +24.52% | +38.70% | +22.73% | +118.21% | - | - | - | 216B | |
| +2.03% | +4.84% | +14.42% | +11.83% | +16.84% | +37.82% | +23.37% | +12.84% | +235.99% | 195B | |
| +0.25% | +3.59% | +9.92% | +11.60% | +8.64% | +49.20% | +87.48% | +85.65% | +241.33% | 159B | |
| -2.90% | -1.81% | +1.48% | +3.91% | +4.83% | +34.67% | +72.24% | +9.90% | +163.03% | 111B | |
| +2.58% | +5.41% | +7.39% | +4.70% | +8.89% | +10.95% | +42.46% | +57.99% | +98.18% | 105B | |
| +4.46% | +10.33% | -12.70% | -14.80% | -18.35% | -9.10% | +235.15% | - | - | 105B | |
| +2.52% | +5.20% | +8.02% | +4.47% | +9.38% | +14.87% | +28.88% | +42.73% | +68.15% | 99.7B | |
| +2.78% | +7.57% | +10.02% | +7.12% | +12.69% | +27.60% | +43.61% | +65.30% | +114.42% | 69.4B | |
| +5.14% | +14.59% | +1.49% | -1.83% | +6.30% | +2.28% | +645.28% | +703.98% | - | 58.11B | |
| +2.13% | +6.71% | +10.39% | +9.82% | +13.52% | +19.64% | +14.55% | -7.46% | -3.52% | 56.79B | |
| +1.96% | +9.36% | +11.19% | +5.53% | +11.22% | +13.14% | +15.35% | +14.85% | +59.16% | 48.98B | |
| +3.30% | +7.50% | +7.07% | +1.25% | +10.47% | +18.92% | +20.02% | +32.58% | +110.18% | 48.26B | |
| +3.05% | +7.26% | +10.40% | +10.54% | +13.68% | +27.37% | +98.08% | +121.46% | +198.32% | 47.53B | |
| +0.99% | +5.22% | +17.38% | +16.70% | +21.20% | +75.25% | +52.66% | +85.72% | +96.21% | 43.63B | |
| +1.79% | +5.94% | +12.07% | +11.86% | +14.50% | +19.81% | +24.83% | +60.03% | +60.80% | 41.05B | |
| +3.42% | +10.73% | +15.60% | +10.13% | +13.01% | +18.77% | +16.56% | +53.90% | -67.11% | 39.92B | |
| -1.71% | -0.38% | +5.54% | -1.28% | +3.23% | +45.05% | +73.02% | +44.19% | +100.76% | 39.09B | |
| +2.40% | +3.92% | +8.14% | +4.34% | +9.80% | +12.45% | +26.27% | +39.42% | +107.99% | 37.69B | |
| +6.52% | +12.41% | +15.03% | +4.33% | +8.23% | +60.18% | +391.03% | +300.44% | +1,699.06% | 37B | |
| +0.27% | +1.77% | +9.03% | +17.92% | +19.94% | -50.66% | -76.96% | -85.92% | - | 30.8B | |
| Average | +1.96% | +5.82% | +9.32% | +7.84% | +10.54% | +27.32% | +96.52% | +90.98% | +205.19% | 79.4B | |
| Weighted average by Cap. | +1.42% | +5.19% | +10.13% | +10.43% | +10.85% | +37.81% | +91.84% | +79.41% | +186.51% |
- Stock Market
- Equities
- GEV Stock
- Sector GE Vernova Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition